{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:15:34Z","timestamp":1794543334190,"version":"4.9.1"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A spectrum of intrapulmonary airway diseases, for example, cigarette smoke\u2013induced bronchitis, cystic fibrosis, primary ciliary dyskinesia, and non\u2013cystic fibrosis bronchiectasis, can be categorized as \u201cmucoobstructive\u201d airway diseases. A common theme for these diseases appears to be the failure to properly regulate mucus concentration, producing mucus hyperconcentration that slows mucus transport and, importantly, generates plaque\/plug adhesion to airway surfaces. These mucus plaques\/plugs generate long diffusion distances for oxygen, producing hypoxic niches within adherent airway mucus and subjacent epithelia. Data suggest that concentrated mucus plaques\/plugs are proinflammatory, in part mediated by release of IL-1\u03b1 from hypoxic cells. The infectious component of mucoobstructive diseases may be initiated by anaerobic bacteria that proliferate within the nutrient-rich hypoxic mucus environment. Anaerobes ultimately may condition mucus to provide the environment for a succession to classic airway pathogens, including Staphylococcus aureus, Haemophilus influenzae, and ultimately Pseudomonas aeruginosa. Novel therapies to treat mucoobstructive diseases focus on restoring mucus concentration. Strategies to rehydrate mucus range from the inhalation of osmotically active solutes, designed to draw water into airway surfaces, to strategies designed to manipulate the relative rates of sodium absorption versus chloride secretion to endogenously restore epithelial hydration. Similarly, strategies designed to reduce the mucin burden in the airways, either by reducing mucin production\/secretion or by clearing accumulated mucus (e.g., reducing agents), are under development. Thus, the new insights into a unifying process, that is, mucus hyperconcentration, that drives a significant component of the pathogenesis of mucoobstructive diseases promise multiple new therapeutic strategies to aid patients with this syndrome.<\/jats:p>","DOI":"10.1513\/annalsats.201806-368aw","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T10:31:50Z","timestamp":1542277910000},"page":"S216-S226","source":"Crossref","is-referenced-by-count":63,"title":["Emerging Concepts and Therapies for Mucoobstructive Lung Disease"],"prefix":"10.1093","volume":"15","author":[{"given":"Marcus A.","family":"Mall","sequence":"first","affiliation":[{"name":"Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Danahay","sequence":"additional","affiliation":[{"name":"Enterprise Therapeutics, University of Sussex, Brighton, East Sussex, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Boucher","sequence":"additional","affiliation":[{"name":"Marsico Lung Institute, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"2026020502215968900_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.med.58.071905.105316","article-title":"Airway surface dehydration in cystic fibrosis: pathogenesis and therapy","volume":"58","author":"Boucher","year":"2007","journal-title":"Annu Rev Med"},{"key":"2026020502215968900_bib2","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib4","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020502215968900_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor\u2013ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respir Med"},{"key":"2026020502215968900_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1183\/20734735.021414","article-title":"Optimising inhaled mannitol for cystic fibrosis in an adult population","volume":"11","author":"Flume","year":"2015","journal-title":"Breathe (Sheff)"},{"key":"2026020502215968900_bib9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00228013","article-title":"CFTR: cystic fibrosis and beyond","volume":"44","author":"Mall","year":"2014","journal-title":"Eur Respir J"},{"key":"2026020502215968900_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1164\/rccm.200901-0069OC","article-title":"Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening","volume":"180","author":"Sly","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib11","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00441-016-2562-z","article-title":"Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases","volume":"367","author":"Zhou-Suckow","year":"2017","journal-title":"Cell Tissue Res"},{"key":"2026020502215968900_bib13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1164\/rccm.201311-1932OC","article-title":"Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis\u2013like lung disease","volume":"189","author":"Gehrig","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib14","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.4049\/jimmunol.0802557","article-title":"Airway and lung pathology due to mucosal surface dehydration in \u03b2-epithelial Na+ channel\u2013overexpressing mice: role of TNF-\u03b1 and IL-4R\u03b1 signaling, influence of neonatal development, and limited efficacy of glucocorticoid treatment","volume":"182","author":"Livraghi","year":"2009","journal-title":"J Immunol"},{"key":"2026020502215968900_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nm1028","article-title":"Increased airway epithelial Na+ absorption produces cystic fibrosis\u2013like lung disease in mice","volume":"10","author":"Mall","year":"2004","journal-title":"Nat Med"},{"key":"2026020502215968900_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1164\/rccm.200708-1233OC","article-title":"Development of chronic bronchitis and emphysema in \u03b2-epithelial Na+ channel\u2013overexpressing mice","volume":"177","author":"Mall","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1165\/rcmb.2013-0407OC","article-title":"Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12\u2013dependent emphysema","volume":"51","author":"Trojanek","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020502215968900_bib18","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1183\/09031936.00149810","article-title":"In vivo monitoring of cystic fibrosis\u2013like lung disease in mice by volumetric computed tomography","volume":"38","author":"Wielputz","year":"2011","journal-title":"Eur Respir J"},{"key":"2026020502215968900_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/mi.2012.17","article-title":"Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation","volume":"5","author":"Livraghi-Butrico","year":"2012","journal-title":"Mucosal Immunol"},{"key":"2026020502215968900_bib20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201708-1616OC","article-title":"Infection is not required for mucoinflammatory lung disease in CFTR-knockout ferrets","volume":"197","author":"Rosen","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/mi.2017.29","article-title":"Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease","volume":"10","author":"Livraghi-Butrico","year":"2017","journal-title":"Mucosal Immunol"},{"key":"2026020502215968900_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature12807","article-title":"Muc5b is required for airway defence","volume":"505","author":"Roy","year":"2014","journal-title":"Nature"},{"key":"2026020502215968900_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm1603","article-title":"Identification of a key pathway required for the sterile inflammatory response triggered by dying cells","volume":"13","author":"Chen","year":"2007","journal-title":"Nat Med"},{"key":"2026020502215968900_bib24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1164\/rccm.201409-1610OC","article-title":"Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease","volume":"191","author":"Fritzsching","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib25","doi-asserted-by":"crossref","first-page":"1700426","DOI":"10.1183\/13993003.00426-2017","article-title":"An informative intragenic microsatellite marker suggests the IL-1 receptor as a genetic modifier in cystic fibrosis","volume":"50","author":"Stanke","year":"2017","journal-title":"Eur Respir J"},{"key":"2026020502215968900_bib26","doi-asserted-by":"crossref","first-page":"1600903","DOI":"10.1183\/13993003.00903-2016","article-title":"Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies","volume":"49","author":"Montgomery","year":"2017","journal-title":"Eur Respir J"},{"key":"2026020502215968900_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients","volume":"109","author":"Worlitzsch","year":"2002","journal-title":"J Clin Invest"},{"key":"2026020502215968900_bib28","first-page":"162","article-title":"Pathogen growth rates in CF sputum are slow and heterogeneous: implications for research and treatment strategies","volume":"51","author":"Newman","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"2026020502215968900_bib29","doi-asserted-by":"crossref","first-page":"e00796-16","DOI":"10.1128\/mBio.00796-16","article-title":"Exposing the three-dimensional biogeography and metabolic states of pathogens in cystic fibrosis sputum via hydrogel embedding, clearing, and rRNA labeling","volume":"7","author":"DePas","year":"2016","journal-title":"MBio"},{"key":"2026020502215968900_bib30","doi-asserted-by":"crossref","first-page":"e00767","DOI":"10.1128\/mBio.00767-15","article-title":"Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation","volume":"6","author":"Cowley","year":"2015","journal-title":"MBio"},{"key":"2026020502215968900_bib31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200708-1151OC","article-title":"Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis","volume":"177","author":"Tunney","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib32","doi-asserted-by":"crossref","first-page":"e1006798","DOI":"10.1371\/journal.ppat.1006798","article-title":"Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children","volume":"14","author":"Muhlebach","year":"2018","journal-title":"PLoS Pathog"},{"key":"2026020502215968900_bib33","doi-asserted-by":"crossref","first-page":"a009738","DOI":"10.1101\/cshperspect.a009738","article-title":"The cystic fibrosis airway microbiome","volume":"3","author":"Lynch","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026020502215968900_bib34","first-page":"e00561-17","article-title":"Cystic fibrosis airway microbiome: overturning the old, opening the way for the new","volume":"200","author":"O\u2019Toole","year":"2018","journal-title":"J Bacteriol"},{"key":"2026020502215968900_bib35","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4049\/jimmunol.175.2.1090","article-title":"Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces","volume":"175","author":"Matsui","year":"2005","journal-title":"J Immunol"},{"key":"2026020502215968900_bib36","doi-asserted-by":"crossref","first-page":"e1005846","DOI":"10.1371\/journal.ppat.1005846","article-title":"Evidence and role for bacterial mucin degradation in cystic fibrosis airway disease","volume":"12","author":"Flynn","year":"2016","journal-title":"PLoS Pathog"},{"key":"2026020502215968900_bib37","doi-asserted-by":"crossref","first-page":"1701910","DOI":"10.1183\/13993003.01910-2017","article-title":"Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis","volume":"51","author":"Dittrich","year":"2018","journal-title":"Eur Respir J"},{"key":"2026020502215968900_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/rccm.201706-1139OC","article-title":"Mucin production and hydration responses to mucopurulent materials in normal versus cystic fibrosis airway epithelia","volume":"197","author":"Abdullah","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1164\/rccm.201712-2554ED","article-title":"Mucopurulent triggering of the airway epithelium. Implications in health and cystic fibrosis","volume":"197","author":"Balazs","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib40","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1183\/09031936.00181209","article-title":"Allergic airway inflammation induces a pro-secretory epithelial ion transport phenotype in mice","volume":"36","author":"Anagnostopoulou","year":"2010","journal-title":"Eur Respir J"},{"key":"2026020502215968900_bib41","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1172\/JCI60429","article-title":"SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation","volume":"122","author":"Anagnostopoulou","year":"2012","journal-title":"J Clin Invest"},{"key":"2026020502215968900_bib42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jaci.2016.09.045","article-title":"Impaired mucus clearance exacerbates allergen-induced type 2 airway inflammation in juvenile mice","volume":"140","author":"Fritzsching","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2026020502215968900_bib43","first-page":"S156","article-title":"Mucus hyperconcentration as a unifying aspect of the chronic bronchitic phenotype","volume":"13","author":"Button","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026020502215968900_bib44","first-page":"S177","article-title":"Unplugging mucus in cystic fibrosis and chronic obstructive pulmonary disease","volume":"13","author":"Mall","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026020502215968900_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000442794","article-title":"Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases","volume":"97","author":"Ha","year":"2016","journal-title":"Pharmacology"},{"key":"2026020502215968900_bib46","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1701632","article-title":"Airway mucin concentration as a marker of chronic bronchitis","volume":"377","author":"Kesimer","year":"2017","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1172\/JCI119138","article-title":"Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea","volume":"99","author":"Wills","year":"1997","journal-title":"J Clin Invest"},{"key":"2026020502215968900_bib49","doi-asserted-by":"crossref","first-page":"C1114","DOI":"10.1152\/ajpcell.00166.2013","article-title":"Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors","volume":"305","author":"Rasgado-Flores","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026020502215968900_bib50","doi-asserted-by":"crossref","first-page":"1702652","DOI":"10.1183\/13993003.02652-2017","article-title":"The in vitro effect of nebulised hypertonic saline on human bronchial epithelium","volume":"51","author":"Goralski","year":"2018","journal-title":"Eur Respir J"},{"key":"2026020502215968900_bib51","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1152\/japplphysiol.00404.2014","article-title":"Duration of action of hypertonic saline on mucociliary clearance in the normal lung","volume":"118","author":"Bennett","year":"2015","journal-title":"J Appl Physiol (1985)"},{"key":"2026020502215968900_bib52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jcf.2018.01.001","article-title":"Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis","volume":"17","author":"Trimble","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2026020502215968900_bib53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","article-title":"Ion channel modulators in cystic fibrosis","volume":"154","author":"Gentzsch","year":"2018","journal-title":"Chest"},{"key":"2026020502215968900_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jcf.2016.12.004","article-title":"Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis","volume":"16","author":"Altes","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2026020502215968900_bib55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib56","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S2213-2600(16)30047-9","article-title":"Pilot evaluation of ivacaftor for chronic bronchitis","volume":"4","author":"Solomon","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2026020502215968900_bib57","article-title":"A safety, tolerability and efficacy study with QBW251 in COPD patients with QBW251","year":"2018"},{"key":"2026020502215968900_bib58","article-title":"Clinical trial results website: generic drug name: QBW251","author":"Novartis Pharmaceuticals","year":"2017"},{"key":"2026020502215968900_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcf.2015.06.002","article-title":"Targeting ion channels in cystic fibrosis","volume":"14","author":"Mall","year":"2015","journal-title":"J Cyst Fibros"},{"key":"2026020502215968900_bib60","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1126\/science.1163518","article-title":"TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity","volume":"322","author":"Caputo","year":"2008","journal-title":"Science"},{"key":"2026020502215968900_bib61","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.09.003","article-title":"Expression cloning of TMEM16A as a calcium-activated chloride channel subunit","volume":"134","author":"Schroeder","year":"2008","journal-title":"Cell"},{"key":"2026020502215968900_bib62","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nature07313","article-title":"TMEM16A confers receptor-activated calcium-dependent chloride conductance","volume":"455","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"2026020502215968900_bib63","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199108223250802","article-title":"Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis","volume":"325","author":"Knowles","year":"1991","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib64","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1172\/JCI114316","article-title":"Chloride secretory response of cystic fibrosis human airway epithelia: preservation of calcium but not protein kinase C\u2013 and A\u2013dependent mechanisms","volume":"84","author":"Boucher","year":"1989","journal-title":"J Clin Invest"},{"key":"2026020502215968900_bib65","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev.physiol.68.072304.112754","article-title":"Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress","volume":"68","author":"Tarran","year":"2006","journal-title":"Annu Rev Physiol"},{"key":"2026020502215968900_bib66","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1113\/jphysiol.2006.126086","article-title":"Differential effects of cyclic and constant stress on ATP release and mucociliary transport by human airway epithelia","volume":"580","author":"Button","year":"2007","journal-title":"J Physiol"},{"key":"2026020502215968900_bib67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1191\/1479972305cd078ra","article-title":"Physiotherapy management of cystic fibrosis","volume":"2","author":"Dodd","year":"2005","journal-title":"Chron Respir Dis"},{"key":"2026020502215968900_bib68","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.rmed.2015.05.018","article-title":"Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis","volume":"109","author":"Wheatley","year":"2015","journal-title":"Respir Med"},{"key":"2026020502215968900_bib69","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcp.22328","article-title":"SLC26A9 stimulates CFTR expression and function in human bronchial cell lines","volume":"226","author":"Avella","year":"2011","journal-title":"J Cell Physiol"},{"key":"2026020502215968900_bib70","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1085\/jgp.200810097","article-title":"SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia","volume":"133","author":"Bertrand","year":"2009","journal-title":"J Gen Physiol"},{"key":"2026020502215968900_bib71","doi-asserted-by":"crossref","first-page":"L593","DOI":"10.1152\/ajplung.00321.2015","article-title":"Generation and functional characterization of epithelial cells with stable expression of SLC26A9 Cl\u2212 channels","volume":"310","author":"Salomon","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020502215968900_bib72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coph.2017.10.002","article-title":"Bypassing CFTR dysfunction in cystic fibrosis with alternative pathways for anion transport","volume":"34","author":"Li","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"2026020502215968900_bib73","first-page":"CD005087","article-title":"Sodium channel blockers for cystic fibrosis","volume":"4","author":"Burrows","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026020502215968900_bib74","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0169-409X(02)00161-8","article-title":"Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents","volume":"54","author":"Hirsh","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"2026020502215968900_bib75","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM199907153410304","article-title":"Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism","volume":"341","author":"Kerem","year":"1999","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib76","first-page":"319","article-title":"Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibroses","volume":"146","author":"Kohler","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"2026020502215968900_bib77","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/S1569-1993(11)60021-0","article-title":"The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease","volume":"10","author":"Zhou","year":"2011","journal-title":"J Cyst Fibros"},{"key":"2026020502215968900_bib78","article-title":"Vertex reports third-quarter 2017 financial results","author":"Vertex","year":"2017"},{"key":"2026020502215968900_bib79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jcf.2017.05.003","article-title":"Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis\u2013like lung disease in mice","volume":"16","author":"Crosby","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2026020502215968900_bib80","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1164\/rccm.201612-2445OC","article-title":"SPX-101 is a novel epithelial sodium channel\u2013targeted therapeutic for cystic fibrosis that restores mucus transport","volume":"196","author":"Scott","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib81","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/cea.13015","article-title":"Corticosteroid and long-acting \u03b2-agonist therapy reduces epithelial goblet cell metaplasia","volume":"47","author":"Lachowicz-Scroggins","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"2026020502215968900_bib82","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1471-4892(01)00045-5","article-title":"The role of epidermal growth factor in mucus production","volume":"1","author":"Nadel","year":"2001","journal-title":"Curr Opin Pharmacol"},{"key":"2026020502215968900_bib83","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1164\/rccm.200909-1415OC","article-title":"Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease","volume":"181","author":"Woodruff","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502215968900_bib84","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2014.12.017","article-title":"Notch2 is required for inflammatory cytokine-driven goblet cell metaplasia in the lung","volume":"10","author":"Danahay","year":"2015","journal-title":"Cell Reports"},{"key":"2026020502215968900_bib85","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature15715","article-title":"Therapeutic antibodies reveal Notch control of transdifferentiation in the adult lung","volume":"528","author":"Lafkas","year":"2015","journal-title":"Nature"},{"key":"2026020502215968900_bib86","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib87","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2013.00129","article-title":"Regulated mucin secretion from airway epithelial cells","volume":"4","author":"Adler","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026020502215968900_bib88","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1113\/jphysiol.2007.149310","article-title":"Munc13-2\u2212\/\u2212 baseline secretion defect reveals source of oligomeric mucins in mouse airways","volume":"586","author":"Zhu","year":"2008","journal-title":"J Physiol"},{"key":"2026020502215968900_bib89","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Pulmozyme Study Group. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"2026020502215968900_bib90","first-page":"CD007168","article-title":"Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis","volume":"7","author":"Tam","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026020502215968900_bib91","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/COPD.S140603","article-title":"Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis","volume":"12","author":"Zeng","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026020502215968900_bib92","first-page":"225","article-title":"Pharmacological approaches to clear mucus from the lungs","volume":"50","author":"Ehre","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"2026020502215968900_bib93","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201802-0245OC","article-title":"An improved inhaled mucolytic to treat airway muco-obstructive diseases","volume-title":"Am J Respir Crit Care Med","author":"Ehre"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/15\/Supplement_3\/S216\/66734387\/annalsats_15_supplement_3_s216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/15\/Supplement_3\/S216\/66734387\/annalsats_15_supplement_3_s216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:22:11Z","timestamp":1770276131000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/15\/Supplement_3\/S216\/8457026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":93,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2018,11,1]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201806-368aw","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,11,1]]}}}